We have reported CD4 CTL as an important effector of high-risk neuroblastoma [5], and work by others on adult cancers has indicated that cytotoxic activity of tumor-specific cytolytic CD4 T cells is in part dependent on SLAMF7 [49]. This evidence concerns the gene SLAMF7 and cancer.